publication date: Oct. 9, 2020Guest EditorialRoy A. Jensen, MDPresident, Association of American Cancer Institutes;Director, The University of Kansas Cancer Center and Kansas Masonic Cancer Research Institute;William R. Jewell Distinguished Kansas Masonic Professor;Professor of pathology and laboratory medicine, anatomy and cell biology, cancer biology and molecular biosciencesKaren E. Knudsen,…
One year after the Centers for Medicare & Medicaid Services made the decision to pay for patient navigation services, data from early adopters show that…
FDA has accepted Bayer’s supplemental new drug application for the oral androgen receptor inhibitor Nubeqa (darolutamide) in combination with androgen deprivation therapy for the treatment…
Exact Sciences Corp. presented three abstracts highlighting advancements in the development of a multi-cancer early detection test at the American Association for Cancer Research Special…
The Biden administration has left NIH in a weakened state, intensifying politicization of science on Capitol Hill and eroding the bipartisan support the government’s premier…
Roy S. Herbst was awarded the Ezra Greenspan Award at the Innovation Gala of The Chemotherapy+ Foundation on Nov. 19 in New York City. To…
Merck announced positive topline results from the pivotal phase III MK-3475A-D77 trial. To access this subscriber-only content please log in or subscribe.If your institution has…
The Biden administration has left NIH in a weakened state, intensifying politicization of science on Capitol Hill and eroding the bipartisan support the government’s premier…
One year after the Centers for Medicare & Medicaid Services made the decision to pay for patient navigation services, data from early adopters show that…
William K. Oh was appointed as service medical director of Smilow Cancer Hospital at Greenwich Hospital, as well as director of precision medicine for Yale…
FDA accelerated approval of Ziihera (zanidatamab-hrii) 50mg/mL for injection for intravenous use for the treatment of adults with previously treated, unresectable or metastatic HER2-positive biliary…
